ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)	3 Months Ended						9 Months Ended		12 Months Ended
	Sep. 30, 2025	Jun. 30, 2025	Mar. 31, 2025	Sep. 30, 2024	Jun. 30, 2024	Mar. 31, 2024	Sep. 30, 2025	Sep. 30, 2024	Dec. 31, 2024	Dec. 31, 2020
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Working capital deficit	$ 394,461						$ 394,461
Accumulated deficit	12,020,049						12,020,049		$ 11,759,600
Cash	95,219						95,219		15,850
Short term note payable	505,755						505,755
Deferred tax liability	195,958						195,958
Net loss	72,837	$ 76,533	$ 111,079	$ 95,537	$ 124,010	$ 262,260	260,449
Net cash used in operating activity							226,863
Goodwill							1,936,020
Goodwill impairment									$ 539,317	$ 623,538
Amortization of financing costs and discounts	0			0			0	$ 840
Accrued warranty liability							0
Sales and marketing expenses	0			0			0	17,403
Product development expenses	0			2,365			125	4,268
Income tax expense							0	0
Income tax benefit	0						0
Stock-based compensation expense	$ 0			$ 0			$ 0	$ 0
Share-Based Payment Arrangement, Option [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount							8,288	208,288
Warrant [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount							199,733	199,733
Preferred B-1 Stock [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount							765,075	15,000
Common Stocks [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount							50,999,900	999,900